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Abstract
Introduction
In 2005, representatives from the Centers for Disease 
Control  and  Prevention  partnered  with  the  National 
Business Group on Health and the Agency for Healthcare 
Research and Quality to form a work group for develop-
ing A Purchaser’s Guide to Clinical Preventive Services: 
Moving Science into Coverage. This guide, designed as a 
tool  for  employers,  describes  recommended  clinical  pre-
ventive services for 46 conditions. The guide includes the 
scientific evidence and benefits language that employers 
need to include comprehensive clinical preventive services 
in their medical benefit plans.
Methods
The  work  group  determined  that  the  guide  would 
address conditions that 1) affected a large percentage of 
the working population, 2) were costly to control, and 3) 
had well-defined and accepted recommendations for pre-
ventive services. Subject matter experts from the Centers 
for Disease Control and Prevention, the National Business 
Group on Health, and the Agency for Healthcare Research 
and Quality developed or reviewed statements of scientific 
evidence for 46 diseases and conditions.
Results
The Purchaser’s Guide, written for an employer audi-
ence,  includes  descriptions  for  recommended  clinical   
preventive services and their cost savings, syntheses of 
supporting  evidence,  strategies  for  prioritization,  and 
recommendations  to  improve  the  delivery  and  use  of 
preventive services. Twelve hundred copies were sent to 
more than 275 members of the National Business Group 
on Health and other purchasers of health care; training 
sessions on the Guide were held for 228 business leaders, 
health benefit consultants, and health plan administra-
tors; and an online version was created through the Web 
sites of the National Business Group on Health and the 
Centers for Disease Control and Prevention. The online 
version  has  received  more  than  260,000  hits  since  its 
release.
Conclusion
In 2007, the National Business Group on Health report-
ed  that  some  Fortune  500  companies  will  be  using  the 
Purchaser’s  Guide  when  negotiating  their  health  ben-
efit contracts and developing their health care strategies. 
Further research is under way to determine whether the 
Guide  influences  employers  to  purchase  recommended 
clinical preventive services.
Introduction
Researchers estimate that 75% of all health care costs 
stem from preventable chronic health conditions, yet only 
1% of the money spent on health care in the United States 
is devoted to protecting health and preventing illness and 
injury (1-3). In addition, chronic health conditions result in 
substantial indirect costs for employers, such as lost pro-
ductivity, absenteeism, and turnover (1). As Americans’ 
health care expenditures continue to increase, strategies 
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that reduce the prevalence and cost of preventable dis-
eases become important. Prevention, early detection, and 
management of diseases can improve our nation’s health 
and reduce health care costs (3).
Clinical  preventive  services,  such  as  screenings,  and 
counseling and treatment for risk factors such as hyper-
tension, lipid disorders, and tobacco use, can help people 
avoid disease and reduce their health risks. Yet health 
care  insurance  benefits  have  historically  been  designed 
to address the treatment of diseases, not their prevention 
(4). National studies have found that adults in the United 
States  receive  approximately  55%  of  the  recommended 
preventive care (4,5).
A  1997  survey  of  3156  employers  revealed  that  most 
employer-sponsored health plans did not cover many of 
the  recommended  clinical  preventive  services  (6).  In  a 
more recent study that used 2001 data from 2180 employ-
ers,  coverage  of  physical  examinations,  immunizations, 
and screenings generally exceeded 50%. Coverage of ser-
vices  that  involved  lifestyle  modification  (e.g.,  nutrition 
counseling)  was  less  than  20%,  however,  even  though 
employers understood the relationship between increased 
productivity, decreased health care costs, and coverage for 
clinical preventive services. In reality, employers in this 
study were least likely to cover the services that were most 
likely to result in a return on their investment (7). Another 
concern is that employers who do cover preventive services 
often use vague contract language (7-8).
Coverage  for  preventive  care  can  determine  whether 
people  receive  preventive  services  (9,10).  For  example, 
a national study of more than 1600 women found that 
women without health insurance had a worse risk fac-
tor  profile  for  cardiovascular  disease  and  used  health 
care services less frequently than did those with health 
insurance (11). Another study of U.S. workers found that 
higher-wage workers were more likely than lower-wage 
workers to have health insurance and health-related ben-
efits and to use preventive services (12). The absence of 
coverage can also have a serious effect on whether physi-
cians offer clinical preventive services. In one study, 31% 
of physicians reported that they sometimes did not offer 
services to their patients because of perceived coverage 
restrictions (13).
Conversely, improvements in insurance coverage may 
increase access to, and use of, preventive health services 
(9,14-16). For example, several years after Medicare began 
covering preventive services, older adults without supple-
mental coverage were approximately 10% less likely to use 
preventive services such as cholesterol testing than those 
who had supplemental coverage (17). In terms of behavior-
al health, managed health plans increasingly include cov-
erage for prevention and health promotion services (18). 
Even though employers understand the need to prevent 
illness  and  disability,  they  rarely  cover  important  pre-
ventive benefits, and they may not follow evidence-based 
recommendations (7). Faced with rising health care costs, 
an  aging  workforce,  and  global  competition,  employers 
are more reliant on retaining employees in the workplace 
past retirement age and on keeping all their employees 
healthy, productive, and engaged (6,19).
In  response  to  these  issues,  in  2006  the  Centers  for 
Disease Control and Prevention (CDC) and the National 
Business Group on Health (NBGH), in collaboration with 
the Agency for Healthcare Research and Quality (AHRQ), 
developed  A  Purchaser’s  Guide  to  Clinical  Preventive 
Services:  Moving  Science  into  Coverage  (19).  This  docu-
ment is a comprehensive tool for employers, particularly 
those who make decisions about which health benefits to 
purchase. It provides guidance for the selection of clinical 
preventive services and ways to manage disease risk that 
the U.S. Preventive Services Task Force (USPSTF), CDC, 
and  other  authoritative  organizations  have  determined 
are  effective.  The  guide  includes  the  scientific  evidence 
and  benefits  language  that  employers  need  to  include 
comprehensive clinical preventive services in their medi-
cal benefit plans. 
The purpose of this article is to give an overview of the 
Purchaser’s Guide and how to use it. We use a scenario 
that illustrates how an employer with several thousand 
employees might use the guide, and we highlight the rec-
ommended clinical preventive services and strategies that 
promote their delivery and use.
Methods
In  February  2005,  representatives  from  CDC,  in 
partnership  with  NBGH,  discussed  the  feasibility  of 
developing  a  decision  support  tool  to  assist  managers 
of employee benefits and human resources in selecting 
and  defining  the  appropriate  benefits  for  clinical  pre-
ventive  services  for  their  employees,  dependents,  and 
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NBGH,  CDC  learned  that  even  NBGH  members  that 
were  sophisticated  and  global  Fortune  500  companies 
lacked the information to select, define, and implement 
evidence-based  preventive  services  as  benefits.  NBGH 
members  requested  information  about  clinical  preven-
tive services that would improve their employees’ health 
and ultimately reduce associated health care costs. At 
the same time, an emerging movement toward consum-
er-directed  health  plans  and  health  savings  accounts 
(HSAs)  has  required  employers  to  specify  the  clinical 
preventive  services  they  will  cover  at  no  cost  to  their 
beneficiaries;  this  practice  is  known  as  “safe-harbor” 
coverage.  For  these  reasons,  we  decided  to  develop  a 
document to guide businesses in the selection of clinical 
preventive services.
Representatives from the CDC and NBGH formed a 
work group to develop the Purchaser’s Guide. Members 
determined  that  the  guide  would  address  conditions 
that  1)  affected  a  large  percentage  of  the  working 
population, 2) were costly to control, and 3) had a well-
defined  and  accepted  recommendation  for  preventive 
service. In the summer of 2005, the work group made 
three  important  tactical  decisions.  First,  it  included 
AHRQ  to  provide  guidance  and  direction.  Second,  it 
expanded the inclusion criteria to all USPSTF A and 
B recommendations (20). Third, the group decided on 
a standard format for each chapter, which significantly 
improved  the  readability  and  consistency  of  informa-
tion in the Purchaser’s Guide.
Beginning in the summer of 2005 and going through the 
early fall of 2006, the work group appointed subject mat-
ter experts, NBGH staff, or both to write evidence state-
ments for 46 health conditions and for other chapters. The 
writers  also  developed  specific  benefit  language,  known 
as  summary  plan  descriptions  (SPDs).  Employers  and 
managers in employee benefits or human resources need 
SPDs to ensure that they include a comprehensive clinical 
preventive services program in their medical benefit plan. 
Work group members extensively reviewed each chapter, 
submitted  the  evidence  statements  through  the  CDC 
clearance process, and delivered the text to NBGH for final 
printing.  In  August  2006,  approximately  12  employers, 
consultants, and experts in prevention reviewed a draft 
of the guide; their feedback was used in making revisions 
before the guide was published.
Results
At a press conference held on November 28, 2006, the 
executive leadership of NBGH, CDC, and AHRQ released 
the Purchaser’s Guide and sent 1200 copies to more than 
275 NBGH members and other purchasers of health care. 
Three “webinars” (seminars on the Web), training sessions, 
and presentations for 228 NBGH business leaders, health 
benefits consultants, and health plan administrators were 
conducted.  The  Purchaser’s  Guide  is  publicly  available 
online  through  the  NBGH  (www.businessgrouphealth.
org/prevention/purchasers) and CDC Web sites (www.cdc.
gov/business)  and  has  received  more  than  260,000  hits 
since its release. In 2006, the University of Washington’s 
Health Promotion Research Center was funded to conduct 
a formal evaluation of the Purchaser’s Guide in the areas 
of employers’ purchasing decisions and coverage for pre-
ventive services.
Chapter  1,  “The  Role  of  Clinical  Preventive  Services 
in  Disease  Prevention  and  Early  Detection,”  provides 
the  rationale  for  endorsing  clinical  preventive  services 
and an overview of all seven chapters in the Purchaser’s 
Guide (Table 1). Because many employers will not be able 
to  cover  all  46  clinical  preventive  services  as  benefits, 
we  present  some  ways  to  prioritize  services,  as  recom-
mended in Chapter 4, “The Prioritization and Strategic 
Implementation of Clinical Preventive Service Benefits.” 
Employers can use each of these methods or a combination 
of them to determine which clinical preventive services 
would be most helpful to their beneficiaries.
1)  Determine  which  clinical  preventive  services 
have the greatest economic and health value. The 
top  20  “high-value”  preventive  services,  rank-ordered 
according to their cost-effectiveness and ability to prevent 
disease, injury, or premature death, are shown in Table 
2 (5). Some high-value services, such as vision screening 
for  adults  older  than  65  years,  are  not  included  in  the 
Purchaser’s Guide because only a small proportion of cov-
ered employees fall into that age group.
2) Address the workforce’s demographic charac-
teristics and health conditions. Employers can evalu-
ate whether their current clinical preventive benefits meet 
the needs of their beneficiary population. Employers with 
heterogeneous populations may decide to choose among 
the  top  20  high-value  preventive  services.  Employers 
with populations that are demographically homogeneous 
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(e.g., mostly male or mostly female, mostly young adults 
[aged 20 to 40 years], or mostly older adults [aged 50 to 70 
years]) may decide to tailor their choice of clinical preven-
tive services benefits to their particular population. For 
a brief summary of clinical preventive services appropri-
ate for different categories defined by age group and sex, 
employers can refer to the charts in chapter 7, “Resources 
and Tools.”
3) Identify which clinical preventive services will 
address the risk profile of a population. Employers 
have  a  variety  of  ways  to  determine  which  conditions, 
diseases, and risk factors are the most prevalent or costly 
to the company. They can get this information by conduct-
ing health risk appraisals, by reviewing data on medical 
or disability claims, by conducting medical evaluations of 
employees, or by doing a combination of these and using 
other sources. Employers can use these results to estab-
lish a group risk profile for their beneficiaries and then 
determine which services would be the most beneficial to 
address specific risks. An example of one scenario for an 
employer is described in the sample scenario in Box 1.
4) Review the evidence statements before choos-
ing clinical preventive services to offer as benefits. 
Chapter 3 includes evidence statements for each of the 
recommended clinical preventive services. In the sample 
scenario, the employer wants to know more about the evi-
dence for each recommended preventive service that will 
address those conditions and risk factors that are preva-
lent  among  its  beneficiaries.  Each  evidence  statement 
includes clinical recommendations made by USPSTF and 
other groups; condition- and disease-specific information; 
and information about the strength of the evidence, the 
economic value of the preventive intervention, and how 
the intervention should be delivered.
On  the  basis  of  the  evidence  statements,  employer  A 
decides  to  implement  high-value  clinical  preventive  ser-
vices and benefits that address the conditions identified 
in the scenario. Employer A also decides to provide safe-
harbor  coverage  for  these  preventive  services  in  HSA- 
qualified  plans  and  to  eliminate  co-pays  for  these   
preventive services in health maintenance organizations,   
preferred  provider  organizations,  and  point-of-service 
plans. The employer also works with a business coalition 
to establish low-cost interventions at the work site, such 
as tobacco-free policies; to provide access to low-cost, nutri-
tious foods in the cafeteria and vending machines; and to 
place mileage markers on a walking course for employees.
5)  Identify  recommended  SPD  language  and 
Current  Procedural  Terminology  (CPT)  codes  for 
the health plan contract. After reviewing the evidence, 
employer A and its health benefits consultant decide to 
improve coverage of selected health benefits. They review 
chapter  2  to  identify  the  SPD  language  statements  for 
each of the recommended clinical preventive services they 
wish to include within their medical benefit plans. The 
employer plans to implement benefits to help beneficiaries 
lead healthy lifestyles to prevent and control the risk fac-
tors and conditions that lead to costly heart attacks and 
strokes. Employer A reviews the Purchaser’s Guide and 
the American Heart Association and American College of 
Cardiology guidelines (21,22) and decides to cover the fol-
lowing SPD recommendations, on the basis of data about 
its employees and the needs of its beneficiaries:
• Aspirin therapy
• Screening for depression
• Screening for diabetes
• Counseling on a healthy diet
• Screening, counseling, and treatment for lipid disorders 
• Screening, counseling, and treatment for hypertension
• Screening for obesity
• Screening, counseling, and treatment for tobacco use
An example of the SPD for hypertension is presented in 
Box 2. CPT codes are provided in the Purchaser’s Guide 
as an appendix to the SPD language statements to ensure 
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Box 1. Sample Scenario
Employer A has 000 employees, 6000 dependents, and 000 retir-
ees. The employer provides coverage for all three groups, including 
Medicare Part B for retirees. The beneficiary population represents 
diverse racial/ethnic groups; 9% are female, and the average age is 
8 years. After a review of the health risk appraisal (HRA) information 
and medical claims data, several diseases and conditions emerge as 
major health or cost problems. Heart attacks, strokes, diabetes, and 
depression account for a high proportion of health care claims and a 
substantial percentage of absenteeism-related costs. The HRA data 
reveals that the prevalence of hypertension and lipid disorders is high 
in this population. A recent employee survey reveals that employees 
would like more assistance to prevent and control these conditions, 
and they want opportunities at the work site to help them lose weight 
and quit smoking. This employer can use this information to cut costs, 
choose benefits, and provide opportunities for health promotion at the 
work site.that  clinical  preventive  services  are  implemented  and 
reimbursed. The American Medical Association developed 
the CPT codes, which are updated annually, to provide a 
uniform  language  that  describes  medical,  surgical,  and 
diagnostic  services  provided  by  clinicians.  Employers 
who adopt the SPD recommendations in the Purchaser’s 
Guide should ensure that administrators of their health 
plan approve the listed CPT codes for reimbursement of 
providers.
6) Determine whether to change or remove cover-
age for services with limited or conflicting evidence 
of  effectiveness  or  with  potential  adverse  effects. 
Some  preventive  services  are  very  effective;  others  are 
ineffective, lack proof of effectiveness, or may be harm-
ful. In chapter 5, the Purchaser’s Guide summarizes the 
USPSTF ratings of clinical preventive services that were 
not  included  as  recommendations  using  the  following 
codes:
• I (insufficient evidence to recommend for or against)
• C (no recommendation either for or against)
• D (recommend against)
Employers should evaluate their current benefits and 
consider removing benefits for services that are ineffective, 
lack sufficient evidence, or are harmful.
7) Look for opportunities to promote the delivery 
and use of preventive services. Providing coverage for 
clinical preventive services is an essential step to improving 
overall employee health. Although coverage is necessary to 
promote the delivery and use of such services, coverage 
alone is not sufficient to optimize the health of employees. 
Employers need to ensure that health plan administrators, 
providers, and beneficiaries know that these benefits exist 
and  should  be  used.  Chapter  6,  “Leveraging  Benefits,” 
identifies  numerous  ways  that  employers  can  promote 
the delivery and use of preventive services to influence 
healthy behavior, such as the following:
• Educate beneficiaries about the importance of clinical 
preventive services in adopting healthy lifestyles.
• Encourage beneficiaries to use covered preventive ser-
vices appropriately.
• Support communitywide activities in disease prevention 
and health promotion.
State and local health departments and other organiza-
tions can assist employers in establishing connections with 
community-based resources to enhance use of preventive 
services.  Chapter  6  also  includes  information  about  the 
CDC  Community  Guide,  which  directs  health  care  pur-
chasers to evidence-based recommendations for population 
health that may enhance their investment in clinical pre-
ventive services. The Community Guide also gives employ-
ers examples of activities to improve the delivery and use 
of  preventive  services,  such  as  using  client  reminders, 
incentives, media, and feedback to providers. This guide 
is available at www.thecommunityguide.org. This chapter 
also gives examples of employers’ successes (Box 3).
8) Establish and evaluate goals for the health of 
beneficiaries.  Employers  should  consider  establishing 
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Box 2. Summary Plan Description Language: Hypertension
Hypertension (Screening)
Covered screening includes conventional measurement with an arm 
cuff and an appropriately validated aneroid (containing no liquid) or 
digital sphygmomanometer (blood pressure meter).
Initiation, cessation, and interval of screening is a covered benefit for 
all children, adolescents, and adults and may be conducted as medi-
cally indicated.
Hypertension (Counseling and Treatment) 
Covered treatment for hypertension includes
•  Counseling to promote therapeutic lifestyle changes
•  Office visits to monitor hypertension and treatment efforts
•  Medications used to treat hypertension
Six counseling, treatment, and monitoring sessions are covered per 
calendar year. Additional counseling sessions are covered as medically 
indicated. Beneficiaries undergoing treatment with hypertension-lower-
ing medications qualify for additional medication management visits, 
as medically indicated.
Box 3. Employer Success Story: Fieldale Farms. 
Fieldale Farms, a poultry processor in Georgia, offered mobile screen-
ing, a gift card, and other incentives to all employees participating in 
its wellness program. Those with elevated blood pressure and high 
cholesterol were offered follow-up nutrition counseling on-site as a 
covered service and received company-paid fitness memberships. Over 
a 5-year period, 26% of the participating employees with high blood 
pressure and high cholesterol normalized these conditions through 
diet changes, medications, and physical activity. For 200, the overall 
health care cost for an employee participating in the Fieldale Farms 
Wellness Program averaged $052, less than half the national average 
health care cost for a manufacturing employee ($6900) (2).VOLUME 5: NO. 2
APRIL 2008
goals  and  benchmarks  to  evaluate  whether  employees’   
health  has  improved  over  time.  Chapter  7,  “Resources 
and  Tools,”  provides  life-course  charts  that  provide  a 
visual guide to clinical preventive services across the life 
span. The chapter also charts and compares the recom-
mendations proposed in the Purchaser’s Guide with the 
2007 Healthcare Effectiveness Data and Information Set 
(HEDIS), the National Committee for Quality Assurance’s 
2007 State of Health Care Quality Report, and the U.S. 
Department  of  Health  and  Human  Services’  Healthy 
People 2010: With Understanding and Improving Health 
and  Objectives  for  Improving  Health  (HP  2010).  In  the 
sample scenario, for example, employer A can decide to use 
any of the goals listed in HP 2010 or the 2007 HEDIS mea-
sures as benchmarks for its beneficiaries. For example, the 
HP 2010 target is to reduce the proportion of adults aged 
20 years or older with hypertension to 16% and to increase 
to 50% the proportion of adults aged 18 years or older who 
have their high blood pressure under control. Employer A 
could track progress toward these goals.
Discussion
A  Purchaser’s  Guide  to  Clinical  Preventive  Services: 
Moving  Science  into  Coverage  is  an  important  tool  for 
employers.  The  Purchaser’s  Guide  translates  clinical 
guidelines and medical evidence into lay terms, providing 
employers with the information they need to select, define, 
and implement 46 preventive medical benefits. Employers 
and health benefits consultants can use the Purchaser’s 
Guide to develop a benefits package that includes preven-
tive services proven to be effective in preventing illness 
and premature death.
The Purchaser’s Guide has some limitations. Although 
the  clinical  recommendations  are  based  on  strong  evi-
dence, information pertaining to the economic benefits was 
lacking for some recommendations. Even so, each chapter 
represents the best available evidence in the published lit-
erature. Second, although the Purchaser’s Guide includes 
advice for improving coverage, it does not comprehensively 
address the policy, educational, and system interventions 
necessary  to  ensure  that  clinicians  deliver  the  preven-
tive  services  and  that  patients  can  access  them.  Third, 
the  comprehensiveness  of  the  recommendations  could 
be overwhelming to employers in a resource-constrained 
environment. On the other hand, the Purchaser’s Guide 
provides different scenarios to help employers prioritize 
and select the services that may be most useful to their 
beneficiaries.
Clinical preventive services can reduce health care costs 
by preventing disease, injury, and disability and by identi-
fying health problems early, when treatment is most effec-
tive and least expensive. Employers play a powerful role in 
shaping health care for many people in the United States. 
They decide what preventive health care services to cover 
in  an  employee’s  health  plan  and  whether  to  establish 
work site programs and policies in health promotion that 
support healthy lifestyles.
The  Purchaser’s  Guide  promotes  the  application  of 
consistent standards for quality care, which will provide 
beneficiaries  better  value  in  their  health  plan.  Perhaps 
most importantly, the Purchaser’s Guide provides succinct 
guidance  to  help  employers  develop  an  overall  strategy 
to phase in effective preventive benefits and to custom-
ize  preventive  programs  for  their  employees.  NBGH 
reports that many Fortune 500 companies will be using 
the Purchaser’s Guide when negotiating their health ben-
efit contracts and developing their health care strategies, 
which could improve the health of millions of employees 
and their dependents.
In an era of limited resources and increased need for 
accountability to improve health outcomes, the Purchaser’s 
Guide helps employers design value-based quality health 
plans.  As  employers  address  rising  health  care  costs 
and the growing burden of chronic disease in the United 
States,  the  Purchaser’s  Guide  will  be  a  useful  tool  for 
developing and evaluating health benefits plans, and will 
allow employers to improve the preventive health services 
they offer. 
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Tables
Table 1. A Purchaser’s Guide to Clinical Preventive Services: Description of Chapters
Chapter Title Description
 The Role of Clinical Preventive Services in Disease 
Prevention and Early Detection
Information for employers on improving the health of beneficiaries and reducing health 
care costs by implementing a comprehensive and structured benefit for clinical preven-
tive services within a medical benefit plan.
2 Summary Plan Description (SPD) Language 
Statements for Recommended Clinical Preventive 
Services Benefits
Forty-six condition-specific SPD language statements designed to assist benefits staff 
as they design, discuss, negotiate, and set benefit structures and coverage guidelines 
with a health plan, union, or consumer group.
 Evidence Statements for Recommended Clinical 
Preventive Service Benefits
Scientific evidence behind each of the 72 recommendations for benefits (i.e., screen-
ing, testing, counseling, immunization, preventive medication, and preventive treat-
ment).
 The Prioritization and Strategic Implementation of 
Clinical Preventive Service Benefits
Practical advice and employer scenarios regarding the strategic implementation of ben-
efits.
5 Clinical Preventive Services: Recommendations 
and Statements of the U.S. Preventive Services 
Task Force (USPSTF)
Information on clinical preventive services that were reviewed by the USPSTF but not 
included in the Purchaser’s Guide. This information may assist benefits staff in deter-
mining which clinical preventive services currently offered in the health plan(s) should 
be re-evaluated.
6 Leveraging Benefits: Opportunities to Promote the 
Delivery and Use of Preventive Services
Actions that employers can take to strengthen prevention efforts by supporting or imple-
menting public health interventions in the workplace and in communities.
7 Resources and Tools Additional information for employers on clinical preventive services, including “at a 
glance” guides to disease prevention throughout the life span and other helpful tools.
 
PDF copies of the Purchaser’s Guide are available on the Web sites of the National Business group on Health (www.businessgrouphealth.org/prevention/pur-
chasers) and the Centers for Disease Control (www.cdc.gov/business). Table 2. High-Value Preventive Servicesa(5), by Rank Order
Service
CPB —  
Maximum Score = 5
CE —  
Maximum Score = 5
Combined Score CPB and CE — 
Maximum Score = 10
Aspirin chemoprophylaxis 5 5 0
Childhood immunization series 5 5 0
Tobacco use, screening and brief intervention 5 5 0
Problem drinking, screening and brief counseling   8
Colorectal cancer screening   8
Hypertension screening 5  8
Influenza immunization   8
Pneumococcal immunization  5 8
Vision screening (adults)  5 8
Cervical cancer screening   7
Cholesterol screening 5 2 7
Breast cancer screening  2 6
Calcium chemoprophylaxis   6
Chlamydia screening 2  6
Vision screening (children) 2  6
Folic acid chemoprophylaxis 2  5
Obesity screening  2 5
Depression screening   
Hearing screening 2 2 
Injury prevention, counseling   
 
CPB indicates clinically preventable burden; CE, cost-effectiveness. 
aEvaluated in terms of the clinically preventable burden of disease and cost-effectiveness.
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